China recently became the world’s largest car exporter, and by all accounts their global market share will keep expanding. One silver lining, at least, is that more and more leaders are figuring out that absent tariff increases, our nation will become a slave to foreign nations that do prioritize production.
The Active Pharmaceutical Ingredient Innovation Center (APIIC), a consortium of biotechnology industry, policy and academic leaders, said in a whitepaper released to the media on Jan. 24, that reshoring the manufacture of essential, life-saving pharmaceuticals was urgently needed.
It’s time to stop the destruction of American industry and innovation, the loss of high-paying manufacturing jobs, and the collapse of communities. We must stop importing more goods than we export, leaving us deeply indebted to our trading partners.
Homeland Security and U.S. Customs face a daunting task in policing the millions of packages full of textile fabrics and apparel that come into the country duty free. They know it. What can be done about it, is the question.
The capacity for China to overproduce anything is legion. This is especially true for big ticket items sold around the world, from cars to steel to China’s top green tech product line – solar cells and modules.
Nelson Cunningham would be the second in command at the USTR after Katherine Tai in his role as Deputy United States Trade Representative.
The Wall Street Journal has started 2024 bemoaning tariffs. They are for losers, the WSJ Inside View columnist Andy Kessler wrote in December, ending 2023 with a taste of what is expected to come this year, an election year.
The House Foreign Affairs Committee said in its hearing on U.S. capital flows to China military companies on Wednesday that it would push the full House to take up legislation that would restrict outbound investment to entire sectors of the Chinese economy.
The Biden administration’s signature clean energy law, the Inflation Reduction Act (IRA), got its clock cleaned last week at a Senate Energy Committee hearing.
This week’s Senate Banking Committee hearing on fentanyl was high on celebrity, short on solutions.
